Divergent immune responses and disease outcomes in piglets immunized with inactivated and attenuated H3N2 swine influenza vaccines in the presence of maternally-derived antibodies

Virology

Volumn 464-465, Issue 1, 2014, Pages 45-54

  Sandbulte, Matthew R ^a   Platt, Ratree ^a   Roth, James A ^a   Henningson, Jamie N ^b   Gibson, Kathleen A ^c   Rajão, Daniela S ^c   Loving, Crystal L ^c   Vincent, Amy L ^c  

^a IOWA STATE UNIVERSITY   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

^c NATIONAL ANIMAL DISEASE CENTER   (United States)

Author keywords

Heterologous immunity; Influenza A; Live attenuated influenza virus; Maternally derived antibodies; Whole inactivated virus

Indexed keywords

INFLUENZA VACCINE; VIRUS ANTIBODY;

ANIMAL; CROSS PROTECTION; FEMALE; GENETICS; IMMUNIZATION; IMMUNOLOGY; INFLUENZA VIRUS A H3N2; MALE; ORTHOMYXOVIRIDAE INFECTIONS; PASSIVE IMMUNIZATION; SWINE; SWINE DISEASES; T LYMPHOCYTE; VETERINARY; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; CROSS PROTECTION; FEMALE; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNIZATION; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; MALE; ORTHOMYXOVIRIDAE INFECTIONS; SWINE; SWINE DISEASES; T-LYMPHOCYTES;

EID: 84904512578     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.06.027     Document Type: Article

References (40)

1. Ambrose C.S., Wu X., Jones T., Mallory R.M. The role of nasal IgA in children vaccinated with live attenuated influenza vaccine. Vaccine 2012, 30(48):6794-6801.
2. Belshe R.B., Gruber W.C., Mendelman P.M., Mehta H.B., Mahmood K., Reisinger K., Treanor J., Zangwill K., Hayden F.G., Bernstein D.I., Kotloff K., King J., Piedra P.A., Block S.L., Yan L., Wolff M. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J. Infect. Dis. 2000, 181(3):1133-1137.
3. Bikour M.H., Cornaglia E., Elazhary Y. Evaluation of a protective immunity induced by an inactivated influenza H3N2 vaccine after an intratracheal challenge of pigs. Can. J. Vet. Res. 1996, 60(4):312-314.
4. Braucher D.R., Henningson J.N., Loving C.L., Vincent A.L., Kim E., Steitz J., Gambotto A.A., Kehrli M.E. Intranasal vaccination with replication-defective adenovirus type 5 encoding influenza virus hemagglutinin elicits protective immunity to homologous challenge and partial protection to heterologous challenge in pigs. Clin. Vaccine Immunol. 2012, 19(11):1722-1729.
5. Cheng X., Zengel J.R., Suguitan A.L., Xu Q., Wang W., Lin J., Jin H. Evaluation of the humoral and cellular immune responses elicited by the live attenuated and inactivated influenza vaccines and their roles in heterologous protection in ferrets. J. Infect. Dis. 2013, 208(4):594-602.
6. Chirkova T.V., Naykhin A.N., Petukhova G.D., Korenkov D.A., Donina S.A., Mironov A.N., Rudenko L.G. Memory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A (H5N2) vaccine. Clin. Vaccine Immunol. 2011, 18(10):1710-1718.
7. Ciacci-Zanella J.R., Vincent A.L., Prickett J.R., Zimmerman S.M., Zimmerman J.J. Detection of anti-influenza A nucleoprotein antibodies in pigs using a commercial influenza epitope-blocking enzyme-linked immunosorbent assay developed for avian species. J. Vet. Diagn. Invest. 2010, 22(1):3-9.
8. Crowe J.E. Influence of maternal antibodies on neonatal immunization against respiratory viruses. Clin. Infect. Dis. 2001, 33(10):1720-1727.
9. De Bruin T.G., Van Rooij E.M., De Visser Y.E., Bianchi A.T. Cytolytic function for pseudorabies virus-stimulated porcine CD4+ CD8dull+ lymphocytes. Viral Immunol. 2000, 13(4):511-520.
10. Denyer M.S., Wileman T.E., Stirling C.M., Zuber B., Takamatsu H.H. Perforin expression can define CD8 positive lymphocyte subsets in pigs allowing phenotypic and functional analysis of natural killer, cytotoxic T, natural killer T and MHC un-restricted cytotoxic T-cells. Vet. Immunol. Immunopathol. 2006, 110(3-4):279-292.
11. Gauger P.C., Vincent A.L., Loving C.L., Henningson J.N., Lager K.M., Janke B.H., Kehrli M.E., Roth J.A. Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A/H1N1 influenza virus. Vet. Pathol. 2012, 49(6):900-912.
12. Gauger P.C., Vincent A.L., Loving C.L., Lager K.M., Janke B.H., Kehrli M.E., Roth J.A. Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (delta-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus. Vaccine 2011, 29(15):2712-2719.
13. Gerner W., Kaser T., Saalmuller A. Porcine T lymphocytes and NK cells-an update. Dev. Comp. Immunol. 2009, 33(3):310-320.
14. He X.S., Holmes T.H., Zhang C., Mahmood K., Kemble G.W., Lewis D.B., Dekker C.L., Greenberg H.B., Arvin A.M. Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J. Virol. 2006, 80(23):11756-11766.
15. Hoft D.F., Babusis E., Worku S., Spencer C.T., Lottenbach K., Truscott S.M., Abate G., Sakala I.G., Edwards K.M., Creech C.B., Gerber M.A., Bernstein D.I., Newman F., Graham I., Anderson E.L., Belshe R.B. Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children. J. Infect. Dis. 2011, 204(6):845-853.
16. Jin H., Zhou H., Liu H., Chan W., Adhikary L., Mahmood K., Lee M.S., Kemble G. Two residues in the hemagglutinin of A/Fujian/411/02-like influenza viruses are responsible for antigenic drift from A/Panama/2007/99. Virology 2005, 336(1):113-119.
17. Kappes M.A., Sandbulte M.R., Platt R., Wang C., Lager K.M., Henningson J.N., Lorusso A., Vincent A.L., Loving C.L., Roth J.A., Kehrli M.E. Vaccination with NS1-truncated H3N2 swine influenza virus primes T cells and confers cross-protection against an H1N1 heterosubtypic challenge in pigs. Vaccine 2012, 30(2):280-288.
18. Khurana S., Loving C.L., Manischewitz J., King L.R., Gauger P.C., Henningson J., Vincent A.L., Golding H. Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease. Sci. Transl. Med. 2013, 5(200). (200ra114).
19. Kitikoon P., Nilubol D., Erickson B.J., Janke B.H., Hoover T.C., Sornsen S.A., Thacker E.L. The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination. Vet. Immunol. Immunopathol. 2006, 112(3-4):117-128.
20. Lanthier P.A., Huston G.E., Moquin A., Eaton S.M., Szaba F.M., Kummer L.W., Tighe M.P., Kohlmeier J.E., Blair P.J., Broderick M., Smiley S.T., Haynes L. Live attenuated influenza vaccine (LAIV) impacts innate and adaptive immune responses. Vaccine 2011, 29(44):7849-7856.
21. Lee J.H., Gramer M.R., Joo H.S. Efficacy of swine influenza A virus vaccines against an H3N2 virus variant. Can. J. Vet. Res. 2007, 71(3):207-212.
22. Loeffen W.L., Heinen P.P., Bianchi A.T., Hunneman W.A., Verheijden J.H. Effect of maternally derived antibodies on the clinical signs and immune response in pigs after primary and secondary infection with an influenza H1N1 virus. Vet. Immunol. Immunopathol. 2003, 92(1-2):23-35.
23. Lorusso A., Vincent A.L., Harland M.L., Alt D., Bayles D.O., Swenson S.L., Gramer M.R., Russell C.A., Smith D.J., Lager K.M., Lewis N.S. Genetic and antigenic characterization of H1 influenza viruses from United States swine from 2008. J. Gen. Virol. 2010, 92(4):12.
24. Loving C.L., Lager K.M., Vincent A.L., Brockmeier S.L., Gauger P.C., Anderson T.K., Kitikoon P., Perez D.R., Kehrli M.E. Efficacy in pigs of inactivated and live attenuated influenza virus vaccines against infection and transmission of an emerging H3N2 similar to the 2011-2012 H3N2v. J. Virol. 2013, 87(17):9895-9903.
25. Loving C.L., Vincent A.L., Pena L., Perez D.R. Heightened adaptive immune responses following vaccination with a temperature-sensitive, live-attenuated influenza virus compared to adjuvanted, whole-inactivated virus in pigs. Vaccine 2012, 30(40):5830-5838.
26. Ma W., Richt J.A. Swine influenza vaccines: current status and future perspectives. Anim. Health Res. Rev. 2010, 11(1):81-96.
27. Masic A., Lu X., Li J., Mutwiri G.K., Babiuk L.A., Brown E.G., Zhou Y. Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs. Vaccine 2010, 28(43):7098-7108.
28. Nelson M.I., Vincent A.L., Kitikoon P., Holmes E.C., Gramer M.R. Evolution of novel reassortant A/H3N2 influenza viruses in North American swine and humans, 2009-2011. J. Virol. 2012, 86(16):8872-8878.
29. Palmer D.F., Coleman M.T., Dowdle W.D., Schild G.O. Advanced Laboratory Techniques for Influenza Diagnosis. Immunology Series No. 6 1975, U.S. Dept. of Health, Education, and Welfare, Washington, D.C.
30. Platt R., Vincent A.L., Gauger P.C., Loving C.L., Zanella E.L., Lager K.M., Kehrli M.E., Kimura K., Roth J.A. Comparison of humoral and cellular immune responses to inactivated swine influenza virus vaccine in weaned pigs. Vet. Immunol. Immunopathol. 2011, 142(3-4):252-257.
31. Reutner K., Leitner J., Mullebner A., Ladinig A., Essler S.E., Duvigneau J.C., Ritzmann M., Steinberger P., Saalmuller A., Gerner W. CD27 expression discriminates porcine T helper cells with functionally distinct properties. Vet. Res. 2013, 44(1):18.
32. Richt J.A., Lager K.M., Janke B.H., Woods R.D., Webster R.G., Webby R.J. Pathogenic and antigenic properties of phylogenetically distinct reassortant H3N2 swine influenza viruses cocirculating in the United States. J. Clin. Microbiol. 2003, 41(7):3198-3205.
33. Rippke B., Mackay D.J.K., Lombard M., Elsken L. Principles of veterinary vaccine production. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2012, 1. OIE. 7th ed.
34. Saalmuller A., Reddehase M.J., Buhring H.J., Jonjic S., Koszinowski U.H. Simultaneous expression of CD4 and CD8 antigens by a substantial proportion of resting porcine T lymphocytes. Eur. J. Immunol. 1987, 17(9):1297-1301.
35. Solorzano A., Webby R.J., Lager K.M., Janke B.H., Garcia-Sastre A., Richt J.A. Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs. J. Virol. 2005, 79(12):7535-7543.
36. Van Reeth K., Labarque G., De Clercq S., Pensaert M. Efficacy of vaccination of pigs with different H1N1 swine influenza viruses using a recent challenge strain and different parameters of protection. Vaccine 2001, 19(31):4479-4486.
37. Vincent A., Awada L., Brown I., Chen H., Claes F., Dauphin G., Donis R., Culhane M., Hamilton K., Lewis N., Mumford E., Nguyen T., Parchariyanon S., Pasick J., Pavade G., Pereda A., Peiris M., Saito T., Swenson S., Van Reeth K., Webby R., Wong F., Ciacci-Zanella J. Review of influenza A virus in swine worldwide: a call for increased surveillance and research. Zoonoses Public Health 2014, 61:4-17.
38. Vincent A.L., Ciacci-Zanella J.R., Lorusso A., Gauger P.C., Zanella E.L., Kehrli M.E., Janke B.H., Lager K.M. Efficacy of inactivated swine influenza virus vaccines against the 2009 A/H1N1 influenza virus in pigs. Vaccine 2010, 28(15):2782-2787.
39. Vincent A.L., Ma W., Lager K.M., Janke B.H., Webby R.J., Garcia-Sastre A., Richt J.A. Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine. Vaccine 2007, 25(47):7999-8009.
40. Vincent A.L., Ma W., Lager K.M., Richt J.A., Janke B.H., Sandbulte M.R., Gauger P.C., Loving C.L., Webby R.J., Garcia-Sastre A. Live attenuated influenza vaccine provides superior protection from heterologous infection in pigs with maternal antibodies without inducing vaccine-associated enhanced respiratory disease. J. Virol. 2012, 86(19):10597-10605.